Viruses Flashcards

1
Q

Nucelocapsid

A

Genetic material and structural proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 types of capsid symmetry

A

Helical/tubular
Icosahedral
Complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Properties of naked vs enveloped virsuses

A

Naked: environmentally stable, spread easily, can survive gut/drying/detergents
Enveloped: environmentally labile, must stay wet, cannot survive GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do naked vs enveloped viruses leave a cell?

A

Naked: cell lysis
Enveloped: budding and cell lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

7 general steps of viral replication

A
Adsorption (attachment)
Entry
Uncoating
Transcription
Synthesis of virus components
Assembly
Release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tropism

A

The interaction between specific proteins on a viral surface and specific receptors on a target cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2 mechanisms of viral entry

A

Endocytosis

Fusion of virus envelope with cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Synthesis of new DNA viruses

A

Replication of DNA in host cell nucleus mediated by viral enzymes
Capsid and other proteins synthesized in cytoplasm using host cell enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are + sense RNA transcribed differently from - sense RNA

A

+: acts as mRNA, viral proteins are made immediately in cytoplasm by viral enzymes
-: first makes a + sense RNA copy via viral enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Reverse transcriptase

A

HIV
Converts + sense viral RNA to cDNA, which is then integrated into host cell chromosome
Host cell enzymes make the mRNA from viral DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 types of persistent viral infections and an example of each

A
  1. Chronic carrier (Hep B)
  2. Latent infection (herpesviridae)
  3. Slow virus infections (Measles virus-Rubeola, due to prolonged incubation period)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Horizontal transmission examples

A
Direct contact
Respiratory
Fomites
Insect vector
Zoonoses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Potential sites of action for antiviral agents

A
Attachment to the host cell
Uncoating of the viral genome
Genome replication
Assembly of progeny virions
Release of virus particles from the host cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does HIV enter the cell?

A

Binds to CD4
Rolls and binds to co-receptor (CCR5 or CXCR4)
Virus cell fusion occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2 general ways to prevent viral attachment

A

Agents that mimic the virus attachment protein and bind to cellular receptors
Agents that mimic the receptor and bind to the viral proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Maraviroc (Celsentry)

A

Selective for CCR5
Blocks the CCR5-gp120 interaction (binds to CCR5)
Prevents CCR5 tropic HIV entry into cells

17
Q

Enfuvirtide (Fuzeon)

A

Mimics amino acids of HIV gp41 that are critical for viral/CD4 cell membrane fusion
Prevents viral entry
Attaches to gp41 and prevents the interaction

18
Q

Nucleoside reverse transcriptase inhibitors

A

Competitive inhibitors of reverse transcriptase
Compete with natural nucleosides
Inhibit chain elongation (lack the OH needed for bonding)

19
Q

Why would you take multiple reverse transcriptase inhibitors at once?

A

So multiple base analogs are present and you can block the inhibition in many places

20
Q

Non-nucleoside reverse transcriptase inhibitors

A

Prevent HIV from using reverse transcriptase by binding at an allosteric site

21
Q

Why would you use multiple drugs to treat HIV?

A

Resistance is rapidly encountered during monotherapy (ex: mutation in the reverse transcriptase)
Can block the proliferation at many different spots
Using more drugs with more targets reduces the emergence of resistant mutants

22
Q

Protease inhibitors

A

Protease inhibitors prevent post-translational cleavage of Gag-Pol polyprotein
Results in immature, noninfectious viral particles
Prevents other cells from being infected

23
Q

Integrase inhibitors

A

Ex: Raltegravir
Binds viral integrase, inhibits strand transfer
Interferes with integration of reverse-transcribed HIV DNA (cDNA) into the chromosome of host cells

24
Q

HAART

A

Highly active anti-retroviral therapy

25
Q

Acyclovir

A

Used to treat herpes
Competition with deoxyGTP for the viral DNA polymerase resulting in:
1. it binding to the DNA template as an irreversible complex
2. chain termination following incorporation into the viral DNA

26
Q

What do the H and N stand for in flu strains?

A

H: hemagglutinin
N: Neuraminidase

27
Q

Amantadine

A

For influenza

Blocks the M2 proton ion channel of the virus and inhibits uncoating of the viral mRNA

28
Q

Tamiflu (oseltamivir)

A

For influenza
Analog of sialic acid (decoy basically)
Interferes with the release of progeny influenza virus from infected to new host cells
Halts the spread of infection
Competitively and reversibly interacts with the active enzyme site to inhibit neuraminidase activity and destroy the receptors recognized by viruses